Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$537M |
| 2 |
Peloton Interactive
PTON
|
+$373M |
| 3 |
Amazon
AMZN
|
+$306M |
| 4 |
S&P Global
SPGI
|
+$244M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$1.27B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$744M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$716M |
| 4 |
AbbVie
ABBV
|
+$712M |
| 5 |
Pinduoduo
PDD
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 16.67% |
| 3 | Consumer Discretionary | 11.17% |
| 4 | Communication Services | 10.86% |
| 5 | Consumer Staples | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
UBS Group
UBS
$173B
| $1.23M | ﹤0.01% |
86,700
-2,179,900
| -96% | -$28.9M |
|
|
MACK
2402
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.22M | ﹤0.01% |
+176,861
| New | +$872K |
|
2403
Nucor
NUE
$61.9B
| $1.21M | ﹤0.01% |
22,800
-195,900
| -90% | -$10.1M |
|
|
TAIT
2404
DELISTED
Taitron Components
TAIT
| $1.21M | ﹤0.01% |
372,974
+41,387
| +12% | +$111K |
|
2405
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.7B
| $1.21M | ﹤0.01% |
23,200
+19,000
| +452% | +$956K |
|
2406
Super Micro Computer
SMCI
$19B
| $1.21M | ﹤0.01% |
+382,400
| New | +$1.08M |
|
|
FLNT
2407
Fluent
FLNT
$114M
| $1.21M | ﹤0.01% |
37,983
-7,784
| -17% | -$153K |
|
|
HALL
2408
DELISTED
Hallmark Financial Services, Inc.
HALL
| $1.21M | ﹤0.01% |
33,970
-4,940
| -13% | -$154K |
|
2409
BeyondSpring
BYSI
$35.8M
| $1.21M | ﹤0.01% |
98,838
+55,540
| +128% | +$730K |
|
|
DCBO
2410
Docebo
DCBO
$520M
| $1.21M | ﹤0.01% |
+18,600
| New | +$986K |
|
2411
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.8B
| $1.2M | ﹤0.01% |
24,000
-2,000
| -8% | -$93K |
|
2412
Corbus Pharmaceuticals
CRBP
$180M
| $1.2M | ﹤0.01% |
32,070
+832
| +3% | +$31.1K |
|
2413
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
| $1.2M | ﹤0.01% |
10,100
+8,000
| +381% | +$896K |
|
|
XENT
2414
DELISTED
Intersect ENT, Inc
XENT
| $1.2M | ﹤0.01% |
52,315
+14,115
| +37% | +$269K |
|
|
INVX
2415
Innovex International
INVX
$2.15B
| $1.2M | ﹤0.01% |
40,400
+3,900
| +11% | +$111K |
|
2416
Tempest Therapeutics
TPST
$14.4M
| $1.19M | ﹤0.01% |
2,857
+113
| +4% | +$39.1K |
|
2417
Summit Therapeutics
SMMT
$10.8B
| $1.19M | ﹤0.01% |
253,212
-50,200
| -17% | -$213K |
|
2418
Amtech Systems
ASYS
$261M
| $1.18M | ﹤0.01% |
185,462
+36,600
| +25% | +$218K |
|
|
LUB
2419
DELISTED
Luby's Inc.
LUB
| $1.18M | ﹤0.01% |
414,852
-25,604
| -6% | -$72.2K |
|
|
PFIE
2420
DELISTED
Profire Energy, Inc
PFIE
| $1.18M | ﹤0.01% |
1,377,812
+26,500
| +2% | +$21.1K |
|
|
PSB
2421
DELISTED
PS Business Parks, Inc.
PSB
| $1.17M | ﹤0.01% |
8,800
-53,400
| -86% | -$6.87M |
|
2422
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.27B
| $1.17M | ﹤0.01% |
35,900
+12,800
| +55% | +$385K |
|
2423
AtriCure
ATRC
$2.01B
| $1.16M | ﹤0.01% |
20,900
-550,475
| -96% | -$23.8M |
|
|
MDP
2424
DELISTED
Meredith Corporation
MDP
| $1.16M | ﹤0.01% |
60,400
+25,600
| +74% | +$416K |
|
|
OPRA
2425
Opera Ltd
OPRA
$1.75B
| $1.16M | ﹤0.01% |
126,800
+114,900
| +966% | +$1.04M |
|
Similar funds
Renaissance Technologies's Q4 2020 Portfolio in Review
As of Q4 2020, Renaissance Technologies held 3,901 positions worth $92.1B, down 8% from $100B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies withdrew a net $21.6B in Q4 2020, closing 555 positions and reducing 1,622 holdings. Its most notable exit was Charter Communications, an estimated $341M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in NVIDIA worth $524M.
- Renaissance Technologies's largest Q4 2020 buy was NVIDIA: 40,123,720 shares worth $524M.
- Renaissance Technologies added most to Amazon in Q4 2020, an estimated $306M increase.
- Renaissance Technologies's biggest Q4 2020 reduction was Zoom, cutting an estimated $1.27B.
- Renaissance Technologies fully exited Charter Communications in Q4 2020, selling an estimated $341M.
- Renaissance Technologies's ten largest holdings make up 13% of its $92.1B portfolio in Q4 2020.
- Renaissance Technologies opened 565 new positions and closed 555 in Q4 2020.
- Renaissance Technologies's portfolio value fell 8% quarter-over-quarter to $92.1B.
Based on Renaissance Technologies's 13F filing for Q4 2020, filed 10 Feb 2021.